Identifying predictors for comorbidities related mortality versus pancreatic cancer related mortality in patients with intraductal papillary mucinous neoplasm

Katsunori Sekine ¹, Naoyoshi Nagata ², Yuya Hisada ³

⁰Department of Gastroenterology and Hepatology, National Center for Global Health and Medicine, Kohnodai Hospital, Ichikawa, Chiba, Japan.

United European Gastroenterology Journal +

|

February 17, 2024

View abstract on PubMed

Summary

Surveillance for intraductal papillary mucinous neoplasm (IPMN) patients should consider main pancreatic duct dilation and mural nodules for pancreatic cancer (PC) risk. A new model predicts comorbidity mortality, aiding in risk stratification for IPMN patients.

Area Of Science

Gastroenterology
Oncology
Radiology

Background

Limited data exist on mortality factors in intraductal papillary mucinous neoplasm (IPMN) patients.
Surveillance decisions for IPMN require better understanding of mortality risks.

Purpose Of The Study

To identify imaging features and patient backgrounds associated with mortality risks in IPMN patients.
To compare risks of pancreatic cancer (PC)-related mortality versus comorbidity-related mortality.

Main Methods

Retrospective multicenter study of 1864 IPMN patients with long-term follow-up.
Competing risk analysis was performed for PC- and comorbidity-related mortality.
A prediction model for comorbidity-related mortality was developed and validated.

Main Results

Main pancreatic duct dilation (≥5 mm) and mural nodules were significantly associated with all-cause and PC-related mortality.
A prediction model for comorbidity-related mortality, including age and various comorbidities, was developed.
The model demonstrated significant association with comorbidity-related mortality in validation cohorts.

Conclusions

Main pancreatic duct dilation and mural nodules are key indicators for PC-related mortality risk in IPMN patients.
A validated prediction model for comorbidity-related mortality can help stratify IPMN patients who may not require intensive surveillance.
This aids in personalized surveillance strategies for IPMN patients, distinguishing between cancer and comorbidity risks.

Keywords:

IPMN intraductal papillary mucinous neoplasm long‐term cohort study mortality prediction model pancreatic cancer pancreatic duct